Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Virginie Marcel

Showing results (51-60 of 57) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 57 results.
Proceedings of the National Academy of Sciences of the United States of America|December 5, 2024
Intricate ribosome composition and translational reprogramming in epithelial-mesenchymal transitionChloé Morin, Agnès Baudin-Baillieu, Flora Nguyen Van Long, et al.
NAR Cancer|July 28, 2021
Erratum: Ribosomal RNA 2' O-methylation as a novel layer of inter-tumour heterogeneity in breast cancerVirginie Marcel, Janice Kielbassa, Virginie Marchand, et al.
NAR Cancer|July 28, 2021
Ribosomal RNA 2'O-methylation as a novel layer of inter-tumour heterogeneity in breast cancerVirginie Marcel, Janice Kielbassa, Virginie Marchand, et al.
Neuro-Oncology|August 2, 2023
Isocitrate dehydrogenase wt and IDHmut adult-type diffuse gliomas display distinct alterations in ribosome biogenesis and 2'O-methylation of ribosomal RNAHermes Paraqindes, Nour-El-Houda Mourksi, Samantha Ballesta, et al.
BMC Cancer|May 11, 2022
Low level of Fibrillarin, a ribosome biogenesis factor, is a new independent marker of poor outcome in breast cancerFlora Nguyen Van Long, Audrey Lardy-Cleaud, Dimitri Carène, et al.
Neuro-Oncology|January 10, 2025
Establishing a living biobank of pediatric high-grade glioma and ependymoma suitable for cancer pharmacologyClémence Deligne, Arthur Tourbez, Flavie Bénard, et al.
Nature Communications|January 11, 2022
Alteration of ribosome function upon 5-fluorouracil treatment favors cancer cell drug-toleranceGabriel Therizols, Zeina Bash-Imam, Baptiste Panthu, et al.
Pageof 6

Showing results (51-60 of 57) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 57 results.
Proceedings of the National Academy of Sciences of the United States of America|December 5, 2024
Intricate ribosome composition and translational reprogramming in epithelial-mesenchymal transitionChloé Morin, Agnès Baudin-Baillieu, Flora Nguyen Van Long, et al.
NAR Cancer|July 28, 2021
Erratum: Ribosomal RNA 2' O-methylation as a novel layer of inter-tumour heterogeneity in breast cancerVirginie Marcel, Janice Kielbassa, Virginie Marchand, et al.
NAR Cancer|July 28, 2021
Ribosomal RNA 2'O-methylation as a novel layer of inter-tumour heterogeneity in breast cancerVirginie Marcel, Janice Kielbassa, Virginie Marchand, et al.
Neuro-Oncology|August 2, 2023
Isocitrate dehydrogenase wt and IDHmut adult-type diffuse gliomas display distinct alterations in ribosome biogenesis and 2'O-methylation of ribosomal RNAHermes Paraqindes, Nour-El-Houda Mourksi, Samantha Ballesta, et al.
BMC Cancer|May 11, 2022
Low level of Fibrillarin, a ribosome biogenesis factor, is a new independent marker of poor outcome in breast cancerFlora Nguyen Van Long, Audrey Lardy-Cleaud, Dimitri Carène, et al.
Neuro-Oncology|January 10, 2025
Establishing a living biobank of pediatric high-grade glioma and ependymoma suitable for cancer pharmacologyClémence Deligne, Arthur Tourbez, Flavie Bénard, et al.
Nature Communications|January 11, 2022
Alteration of ribosome function upon 5-fluorouracil treatment favors cancer cell drug-toleranceGabriel Therizols, Zeina Bash-Imam, Baptiste Panthu, et al.
Pageof 6